{
  "id": "mhgap#risk_safety_24fd20dd",
  "title_en": "General — Risk Safety",
  "title_vi": "General — Nguy cơ An toàn",
  "text_en": "one year post-remission, response or the first three months (63.9%) and first six months recovery, is very low. (another 22.6%). The difference in relapse-free rates y The certainty of evidence is low for relapse rates at becomes much smaller after six months. six months post-remission between antidepressants y The relapse rate at one year was lower for and pill placebo. pharmacotherapy compared with placebo. The 59 Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders Remarks Implementation considerations y The term “depression” refers to moderate-to-severe y Long-term antidepressant use may be associated depressive episode or disorder. with additional adverse effects such as weight gain. y The term “remission” is defined as relief from y Specific types of antidepressants selected should depressive symptoms. carefully consider factors such as demographic y The studies identified in the review included characteristics (e.g. higher risks that may be people experiencing first or recurrent episodes associated with pregnancy or older age) and of depression. side-effects profiles (e.g. sexual dysfunction, sleep y Antidepressants are typically most effective in the problems, weight gain). initial 6–12 months and should only be continued y When discontinuing antidepressants, abrupt where there is need and clinical oversight. discontinuation should be avoided and medicine doses should be tapered off slowly. Any withdrawal Research gaps symptoms should be closely monitored. y Most of the research is from HICs. Further research is y Providers should keep in mind the possible adverse needed in LMICs. effects associated with antidepressants, the ability y More research is needed to investigate the to deliver either intervention (in terms of expertise, relationship between the number of depressive and/or treatment availability) and individual episodes and optimal treatment duration. preferences. Discontinuities in drug availability y More research is needed to examine the evidence (common in LMICs) may interfere with continuation to evaluate adverse effects regarding the duration of treatment. of treatment. y Costs accumulate with duration of prescription. y Further research is needed on how best to support Cost of daily dose of generic antidepressants varies individuals in managing withdrawal symptoms when from region to region throughout the world ranging stopping antidepressant medicines and guidance between 3% and 9% of minimum wage (131). for clinicians on tapering of antidepressants and management of withdrawal symptoms. 60",
  "gloss_vi": "One year post-remission, response or the first three months (63.9%) and first six months recovery, is very low. (another 22.6%).",
  "source": "WHO mhGAP-IG 2023",
  "url": "https://www.who.int/",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "risk_safety",
      "screening_cues",
      "referral",
      "psychoeducation",
      "do_not_do",
      "management"
    ],
    "life_topics": [
      "sleep",
      "study",
      "relationships"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Risk Safety General — Nguy cơ An toàn one year post-remission, response or the first three months (63.9%) and first six months recovery, is very low. (another 22.6%). The difference in relapse-free rates y The certainty of evidence is low for relapse rates at becomes much smaller after six months. six months post-remission between antidepressants y The relapse rate at one year was lower for and pill placebo. pharmacotherapy compared with placebo. The 59 Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders Remarks Implementation considerations y The term “depression” refers to moderate-to-severe y Long-term antidepressant use may be associated depressive episode or disorder. with additional adverse effects such as weight gain. y The term “remission” is defined as relief from y Specific types of antidepressants selected should depressive symptoms. carefully consider factors such as demographic y The studies identified in the review included characteristics (e.g. higher risks that may be people experiencing first or recurrent episodes associated with pregnancy or older age) and of depression. side-effects profiles (e.g. sexual dysfunction, sleep y Antidepressants are typically most effective in the problems, weight gain). initial 6–12 months and should only be continued y When discontinuing antidepressants, abrupt where there is need and clinical oversight. discontinuation should be avoided and medicine doses should be tapered off slowly. Any withdrawal Research gaps symptoms should be closely monitored. y Most of the research is from HICs. Further research is y Providers should keep in mind the possible adverse needed in LMICs. effects associated with antidepressants, the ability y More research is needed to investigate the to deliver either intervention (in terms of expertise, relationship between the number of depressive and/or treatment availability) and individual episodes and optimal treatment duration. preferences. Discontinuities in drug availability y More research is needed to examine the evidence (common in LMICs) may interfere with continuation to evaluate adverse effects regarding the duration of treatment. of treatment. y Costs accumulate with duration of prescription. y Further research is needed on how best to support Cost of daily dose of generic antidepressants varies individuals in managing withdrawal symptoms when from region to region throughout the world ranging stopping antidepressant medicines and guidance between 3% and 9% of minimum wage (131). for clinicians on tapering of antidepressants and management of withdrawal symptoms. 60 One year post-remission, response or the first three months (63.9%) and first six months recovery, is very low. (another 22.6%)."
}